ARMATA PHARMACEUTICALS, INC. (ARMP)
(90% Positive) ARMATA PHARMACEUTICALS, INC. (ARMP) Provides Update on need for AP-SA02 Enables more frequent FDA engagement
(90% Positive) ARMATA PHARMACEUTICALS, INC. (ARMP) Provides Update on need for AP-SA02 Enables more frequent FDA engagement
📋 ARMATA PHARMACEUTICALS, INC. (ARMP) - Clinical Trial Update
Filing Date: 2026-05-07
Accepted: 2026-05-07 07:10:56
Event Type: Clinical Trial Update
Event Details:
🔬 Clinical Development Pipeline (ARMATA PHARMACEUTICALS, INC.):
💼 Business Developments:
Structured Data: